Ribonuclease Gold Labels Heparin in Human Mast Cell Granules: New Use for an Ultrastructural Enzyme Affinity TechniqueAnn M. Dvoraka and Ellen S. Morganaa Departments of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts Correspondence to: Ann M. Dvorak, Dept. of Pathology/East Campus, Beth Israel Deaconess Medical Center, 330 Brookline Ave., Boston, MA 02215. We evaluated an enzyme affinitygold ultrastructural technique designed to identify RNA-rich structures, based on an RNasegold (RG) probe in human mast cells (HMCs). As expected, the RG technique labeled RNA-containing ribosomes and nucleoli in HMCs. The heparin-rich secretory granules in HMCs were also labeled. Extensive studies revealed that HMCs isolated from lung or skin and sustained in short-term cultures, derived de novo in growth factor-supplemented cord blood cell cultures, or present in vivo in multiple sites all shared this property. We performed a large number of controls designed to examine the HMC granule binding characteristics of gold alone, of irrelevant protein or enzymegold reagents, of the role of charge and enzyme activity after various enzyme digestions, after blocking with macromolecules, after exposure to inhibitors of RNase, of heparin, or to irrelevant enzyme inhibitors, including staining of macromolecule-containing test agar blocks and a variety of combined absorption and digestion experiments of the binding of RG to HMC granules. These studies established that the RG method detected heparin in this site in conventionally prepared, well-preserved electron microscopic samples. These findings demonstrate a new use for this enzyme affinitygold technique in mast cell biology, based on the known property of heparin as an inhibitor of RNase. (J Histochem Cytochem 46:695706, 1998) Key Words: enzyme affinitygold technique, human mast cell, granules, RNA, heparin, ribosomes, electron microscopy
This article has been cited by other articles:
|
|
||||||||||||||||||||||||||||||||||||||